Stereotactic ablative radiotherapy in the framework of classical radiobiology: Response to Drs. Brown, Diehn, and Loo

International Journal of Radiation Oncology Biology Physics

Volumn 79, Issue 5, 2011, Pages 1599-1600

  Meyer, Jeffrey ^a   Timmerman, Robert ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

CELL KILLING; CELL SURVIVAL; DOSIMETRY; HUMAN; HYPOXIA; IN VITRO STUDY; LETTER; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIOBIOLOGY; RADIOSENSITIVITY; REOXYGENATION; STEREOTACTIC BODY RADIATION THERAPY; STEREOTACTIC RADIOSURGERY; TUMOR CELL;

CELL HYPOXIA; CELL SURVIVAL; DOSE FRACTIONATION; HUMANS; LINEAR MODELS; OXYGEN CONSUMPTION; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; RADIOSURGERY;

EID: 79952653655     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.11.014     Document Type: Letter

References (9)

1. Brown JM, Diehn M, Loo BW Jr. Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer. Int J Radiat Oncol Biol Phys 2010;78:323-327.
2. Garcia-Barros M, Paris F, Cordon-Cardo C, et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003;300:1155-1159. (Pubitemid 36583102)
3. Lee Y, Auh SL,Wang Y, et al. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: Changing strategies for cancer treatment. Blood 2009;114:589-595.
4. Tanasichuk H, Urtasun RC, Fulton DS, et al. Misonidazole with dexamethasone rescue: An escalating dose toxicity study. Int J Radiat Oncol Biol Phys 1984;10:1735-1737. (Pubitemid 14018290)
5. Powers WE, Tolmach LJ. A multicomponent x-ray survival curve for mouse lymphosarcoma cells irradiated in vivo. Nature 1963;197:710-711.
6. Fowler JF, Sheldon PW, Denekamp J. Optimum fractionation of the C3H mouse mammary carcinoma using x-rays, the hypoxic-cell radiosensitizer Ro-07-0582, or fast neutrons. Int J Radiat Oncol Biol Phys 1976;1:579-592.
7. Zhao D, Jiang L, Hahn EW. Comparison of 1H blood oxygen level-dependent (BOLD) and 19F MRI to investigate tumor oxygenation. Magn Reson Med 2009;62:357-364.
8. O'Donoghue JA, Zanzonico P, Pugachev A, et al. Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis (N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models. Int J Radiat Oncol Biol Phys 2005;5:1493-1502. (Pubitemid 40470433)
9. Lin Z, Mechalakos J, Nehmeh S, et al. The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-MISO positron emission tomography. Int J Radiat Oncol Biol Phys 2008;70:1219-1228. (Pubitemid 351296122)